Skip to main navigationSkip to News Headlines
NJ Division of Consumer Affairs
Global Navigation
Division of Consumer Affairs
The State of New Jersey Office of The Attorney General (Dept. of Law & Public Safety) The State of New Jersey NJ Home Services A to Z Departments/Agencies OAG Frequently Asked Questions
OAG Home
OAG Contact
Division of Consumer Affairs Alerts and Recalls
Division of Consumer Affairs Alerts and Recalls
Office of the Attorney General Homepage Division of Consumer Affairs, Director
Division of Consumer Affairs, Director
Division of Alcoholic Beverage Control
Division of Consumer Affairs
Division of Consumer Affairs Highlights
Division of Consumer Affairs Topics in a A-Z List Format
Office of Consumer Protection (OCP)
New Jersey Bureau of Securities
Office of Weights and Measures
Legalized Games of Chance Control Commission
Alternative Dispute Resolution
Professions and Occupations List
Contact the Division of Consumer Affairs
Division of Consumer Affairs in Spanish
Division of Criminal Justice
Division on Civil Rights
Division of Gaming Enforcement
Division of Highway Traffic Safety
Division of Law
Juvenile Justice Commission
NJ Racing Commission
State Athletic Control Board
Division of NJ State Police
Victims of Crime Compensation Office
OPRA - Open Public Records Act
Download Free PDF Reader

Paula T. Dow,
Attorney General

Division of Consumer Affairs
Thomas R. Calcagni, Director


Bureau of Securities
Abbe R. Tiger, Chief

For Immediate Release:
July 19, 2011
For Further Information Contact:
Jeff Lamm, 973-504-6327
Neal Buccino, 973-504-6327

New Jersey Attorney General and Division of Consumer Affairs Announce Bureau of Securities Lawsuit Against Bergen County Companies and Their CEO/Managing Member for Alleged Investor Fraud

NEWARK – The New Jersey Bureau of Securities, within the State Division of Consumer Affairs, has filed suit against an Allendale-based company, its top executive and his wife, and two other business entities, alleging that nearly 800 investors were defrauded of approximately $9.5 million through the sale of unregistered stock and notes and the subsequent misuse of the invested funds.

Thomas J. Fagan ("Fagan"), President and CEO of Energex Systems, Inc., allegedly violated the State’s Uniform Securities Law by using the funds raised from investors for personal expenses for himself and his wife, Candace Fagan. Fagan was not registered as an agent with the N.J. Bureau of Securities when he sold approximately $9.5 million in unregistered Energex stock.

The State’s nine-count Complaint and Order to Show Cause, filed in State Superior Court in Hackensack, names as defendants Fagan; Candace Fagan; Energex Systems, Inc.; Arbios Acquisition Partners, LLC; and Arbios Systems, Inc.

Fagan founded Arbios Acquisition Partners in 2009 to gain control of Arbios Systems, Inc., and allegedly sold unregistered ASI promissory notes and ASI stock to investors. According to the Complaint, Fagan allegedly commingled investors’ funds among the entities he controlled and misused approximately $2.3 million for his personal benefit and enrichment.

"The complaint outlines how Fagan allegedly used investors’ hard-earned money as his personal piggy bank, misspending corporate funds for personal travel to Atlantic City and Las Vegas casinos and to see the Olympics in Europe," Attorney General Paula T. Dow said. "We are bringing this action to hold Fagan accountable."

The state is seeking court approval to freeze the defendants’ assets and the appointment of a receiver, as well as enjoining Fagan from engaging in any securities-related activity. According to Delaware records, where the defendant businesses were incorporated or formed, Energex is no longer in existence. Arbios Acquisition Partners exists but is not in good standing. Arbios Systems, Inc. exists and its stock is traded on the Over-the-Counter Bulletin Board (OTCBB).

"As alleged in our Complaint, Fagan cheated investors by distorting the line between his personal and business expenses, misappropriating investor money that he controlled. Through this lawsuit, we’re seeking to place Fagan on the hook for his actions and put an end to the investor deception," said Thomas R. Calcagni, Director of the State Division of Consumer Affairs.

Energex Systems, Arbios Acquisition Partners, and Arbios Systems, Inc., all listed the same Allendale address as their business location. Energex Systems, formerly known as Orthomedics and Orthosonix, claimed to be in the business of various biotech products, including ones related to blood safety.

"Investors need to be alert to persons who are violating New Jersey’s Securities Law by offering and selling securities without proper registrations. The Bureau of Securities can assist investors in performing due diligence," said Abbe R. Tiger, Bureau Chief. "The Bureau of Securities will do everything in its power to be vigilant in shutting down fraud schemes, but we need to hear from those who believe they may be victims."

The Bureau of Securities can be contacted toll-free within New Jersey at 1-866-I-INVEST (1-866-446-8378) or from outside New Jersey at 973-504-3600. The Bureau's website is located at

Rudolph G. Bassman, Chief of Enforcement for the Bureau of Securities, conducted the investigation of this case. Deputy Attorneys General Victoria A. Manning and Paul E. Minnefor of the Securities Fraud Prosecution Section in the Division of Law, are representing the Bureau.

View Complaint


Contact Us | Privacy Notice | Legal Statement | Accessibility Statement
NJ Home Logo
Divisional: DCA Home | Complaint Forms | Proposals | Adoptions | Contact DCA
Departmental: OAG Home | Contact OAG | About OAG | OAG News | OAG FAQs
Statewide: NJ Home | Services A to Z | Departments/Agencies | FAQs
Copyright © State of New Jersey, 1996-2007
This page is maintained by DCA. Comments/Questions: email

Page last modified: